<DOC>
	<DOCNO>NCT00310505</DOCNO>
	<brief_summary>This study conduct assess safety efficacy amphotericin B deoxycholate dose 0.75 mg/kg 1.0 mg/kg 15 dos . In arm drug give conventional way every alternate day daily administration regimen test .</brief_summary>
	<brief_title>Amphotericin B Treatment Visceral Leishmaniasis</brief_title>
	<detailed_description>This study conduct assess safety efficacy amphotericin B deoxycholate dose 0.75 mg/kg 1.0 mg/kg 15 dos . In arm drug give conventional way every alternate day daily administration regimen test .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Visceral</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Amphotericin B , deoxycholate drug combination</mesh_term>
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Parasitologically prove kalaazar HIV positive serology</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>visceral leishmaniasis</keyword>
	<keyword>amphotericin B</keyword>
	<keyword>Kala-azar</keyword>
</DOC>